h
Contact info

Long-term value for all customers

Lorem ipsum dolor sit amet, consetetur sadi pscing elitr, sed diam nonumy eirmod tempor invidun omni sum.

WHO WE ARE

About our Company

Our Vision

A world where science and critical thinking replace simplistic solutions—advancing metabolic care and policy to honour and improve lives.

Our Mission

To help organisations address complex metabolic health challenges by bridging global insight with local realities and sharp focus with the bigger picture, while building common ground across divergent perspectives to improve care and policy in obesity and metabolic disease.

Our Philosophy

Balanced advice does not mean splitting the difference. It means finding what holds after every credible alternative has been tested.

OUR STORY

25 years of research, rigour and consensus.

A specialist consultancy built on its founders' 25 years of convening the world's leading experts to resolve the hardest questions in metabolic health. Every initiative relied on leading experts across disciplines and countries. MHI now mobilises that network to improve the lives of people living with obesity and metabolic disease.
WHY CHOOSE US

What makes MHI different was learned, not designed.

Architects, not observers

Our founders led the global initiatives that contributed to redefine obesity diagnosis and treatment.

A proven consensus method

Refined over 25 years of international commissions. Divergent views resolved, never averaged.

Convening power, global research

Founders in five countries, and congresses drawing experts from over 70.

Credible across the ecosystem

Independent conclusions that industry, payers, clinicians and policymakers accept.

Science, governance and finance aligned

Two co-founders led FTSE 100 companies and NHS hospital finance, so advice holds in the boardroom as well as the clinic.

THE TEAM

Engaging the best expertise, wherever it is

Together the founding team forms MHI's advisory board. MHI also draws on world-leading clinicians, researchers, trialists, health economists, policy experts and patient representatives, engaged for each question.
francesco2

Chair of Metabolic and Bariatric Surgery, King's College London. Led the Diabetes Surgery Summit and Lancet Commission on Clinical Obesity.

Prof. Francesco Rubino

Founder- United Kingdon
user-2

Director, Bariatric and Metabolic Institute, Pennington Biomedical. Past President, ASMBS.

Prof. Philip R. Schauer

Co-Founder- USA
francesco2

Director, Center for Obesity and Diabetes, Oswaldo Cruz German Hospital. Past President, IFSO.

Dr. Ricardo Cohen

Co-Founder- Brazil
about-us-team-img2

Chief, Obesity and Related Disorders, Catholic University, Rome. Visiting Professor, King's College London.

Prof. Geltrude Mingrone

Co-Founder- Italy
francesco2

Professor of Medicine, University of Washington. Director, Weight Management Clinic, VA Puget Sound.

Prof. David Cummings

Co-Founder- USA
user-2

Professor of Experimental Pathology, University College Dublin. NIHR Clinician Scientist Award.

Prof. Carel le Roux

Co-Founder- Ireland
francesco2

40+ years leading complex healthcare and multinational organizations, including as CEO of FTSE 100 companies.

Ian Smith, MBA MA

Co-Founder- United Kingdom
about-us-team-img2

CPFA with 25 years in healthcare finance, including 13 as CFO of a major NHS teaching hospital.

Simon Taylor

Co-Founder- Untied Kingdom
START A CONVERSATION

BRING US YOUR HARDEST QUESTIONS.